Statins and hypertension (Q83283656)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16673013%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Statins and hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16673013%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Wierzbicki AS

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16673013%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

4 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16673013%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16673013%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16673013%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16673013%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

554-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16673013%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Statins for stroke prevention: disappointment and hope

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

1 reference

7 January 2021

Statin therapy and stroke prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

The lipid and non-lipid effects of statins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Association between carotid haemodynamics and inflammation in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Cardiovascular risk factors and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Insights into human hypertension: the role of endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Relations of longitudinal left ventricular systolic function to left ventricular mass, load, and Doppler stroke volume

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Targeting endothelial dysfunction in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Aspirin and endothelial function in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Endothelial dysfunction: does it matter? Is it reversible?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Assessment and treatment of endothelial dysfunction in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Nonhypoglycemic effects of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Hyperlipidaemia, hypertension, and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Lipid lowering: another method of reducing blood pressure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002032

7 January 2021